RB1 and neoplasm: Recent findings by Zhang et al. [42] suggest that Rb can also be deactivated independently of CDK phosphorylation, such as through altered upstream signaling pathways or viral oncoprotein interactions, further inducing LOF mutations and nullifying its tumor-suppressor capabilities.